Physician profile
Bradley Rector
NPI 1205262235
$447.75
in general payments reported to CMS, 2019-2025
11 companies · $20.21 in 2025
The $20.21 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.95 · 2022: $293 · 2023: $92.84 · 2025: $20.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $85.18 | 2022 | |
| Jazz Pharmaceuticals INC. | $74.94 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $57.54 | 2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $46.96 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $45.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $42.68 | 2022-2023 | Xarelto |
| Mylan Specialty L.P. | $29.41 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.21 | 2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $16.75 | 2023 | Zerbaxa, Dificid, Recarbrio |
| Electromed, INC. | $15.15 | 2022 | |
| Insmed, INC. | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Rector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.